General Info

  1. March 29, 2024

    Proud to be Certified™ by Great Place To Work®

    FOR IMMEDIATE RELEASE

    REVELATION PHARMA Attains Prestigious Great Place To Work Certification™ for 2024-2025 

    Castle Rock, Colorado – March 29, 2024 – Revelation Pharma is thrilled to announce its official certification as a Great Place To Work® for the 2024-2025 period. This esteemed recognition marks the culmination of dedicated efforts and reflects the unwavering commitment of every member of the Revelation team to foster a positive and supportive workplace environment.

    As stated by Susann Caputo, Senior Vice President of Human Resources at Revelation Pharma, "Achieving certification as a Great Place to Work is a significant accomplishment that reflects the dedication and efforts of every member of our team. It's a validation of our commitment to creating a positive and supportive environment where every individual feels valued, empowered, and inspired to do their best work."

    The Great Place To Work Certification™ is awarded based entirely on feedback

    Read More
  2. March 26, 2024

    Kasra Moaddel Joins Revelation Pharma

    FOR IMMEDIATE RELEASE

    Kasra Moaddel Joins Revelation Pharma as Vice President of Corporate Development

    Tampa, FL - Revelation Pharma proudly welcomes Kasra Moaddel as the newest addition to its leadership team, assuming the role of Vice President of Corporate Development. With a stellar background in mergers & acquisitions (M&A) and corporate development, Moaddel brings a wealth of experience and strategic insight to drive Revelation Pharma's growth and expansion initiatives.

    Throughout his distinguished career, Moaddel has made significant contributions to esteemed healthcare entities, leaving a lasting impact on the industry. Particularly noteworthy is his instrumental role in shaping the corporate development and strategy of a prominent healthcare organization in Southern California. His strategic foresight and leadership played a pivotal role in establishing the organization as a key player in the region's healthcare scene.

    Read More
  3. February 27, 2024

    A Guide to Writing a Compounded Prescription for Hormone Replacement Therapy (HRT)

    Zoom-header2

    Hormone Replacement Therapy (HRT) is a treatment option widely prescribed for patients experiencing various symptoms related to hormonal imbalances. Compounded prescriptions for HRT allow healthcare practitioners to tailor medications specific to individual patient’s needs, providing a more personalized approach to therapy. This blog will guide practitioners through writing a compounded prescription for Hormone Replacement Therapy to ensure optimal patient care and treatment outcomes.

    1. Patient Assessment

    Before writing a compounded prescription for HRT, it is critical to conduct

    Read More
  4. January 30, 2024

    Ketamine ain’t esketamine

    Ketamine’s been in the news a lot as a potential treatment for depression, PTSD, and more. It’s not FDA-approved (yet), but its cousin esketamine is approved for treating some forms of depression.

    That gets confusing, especially among lay people who don’t realize how important those extra two letters are. (Consider how you’d feel if you landed in Kansas instead of Arkansas, especially during tornado season.)

    Luckily, the good folks at Medscape have a great overview of the differences between ketamine and esketamine, including how they’re delivered, what they’re approved for, and the issues popping up as clinics offer “treatment” that could be ineffective, dangerous, or somewhere in between.

    While ketamine and esketamine are chemically related, they are very distinct in terms of their chemical compositions, the FDA-approved indications, dosing, and administration, as well as the level of study and data

    Read More
Page